Potential dilution from the exercise of stock acquisition rights
First written in FY2016. 20 of 28 entries say "Materialised", first in FY2017-Q4. Latest entry: 2026-06-26.
iRidge moved to the "Worse" side of this theme in 2017, 4 years before the typical company in this theme (2021).
The whole theme swung hardest in 2017: 28 of 54 companies on the "Worse" side.
33 other companies' latest entry also says "Worsened".
- 2026-06-26WorsenedShare Issuance and Disposal
「If all of these stock acquisition rights are exercised, the total number of common shares of the company that would be newly issued would represent a maximum of approximately 1.0% of the number of shares issued as of the end of the fiscal year ending March 2026 for each of the 12th and 13th stock acquisition rights.」
The issuance of the 12th and 13th stock acquisition rights newly indicates potential share issuance equivalent to approximately 2.0% in total at maximum, increasing exposure to dilution of shareholder value. - FY2025-H1WorsenedAnnual report
「Class, description and number of shares underlying the stock acquisition rights (shares)* Common shares 325,100 (Note 2)」
The issuance of the 11th series of stock acquisition rights newly established 325,100 potential shares for the company's directors and employees and the officers and employees of its subsidiaries, increasing dilution exposure. - FY2024MaterialisedAnnual report
「The 106,500-share increase in issued common shares comprised a 30,900-share increase from grants of restricted stock compensation and a 75,600-share increase from the issuance of new shares through the exercise of stock acquisition rights issued as stock options.」
During the consolidated fiscal year, 75,600 shares were issued through the exercise of stock acquisition rights. After the filing date, a further 358,400 shares were issued through a third-party allotment, and dilution continues to materialise through actual share issuance. - FY2024-Q1MaterialisedAnnual report
「1 April 2023–30 June 2023 10,800 (Note) Increase due to the exercise of stock acquisition rights.」
10,800 shares were added through the exercise of stock acquisition rights during the first quarter, and dilution continues to materialise through actual share issuance. - FY2023MaterialisedAnnual report
「The 74,400-share increase in issued common shares comprised a 20,000-share increase from grants of restricted stock compensation and a 54,400-share increase from the issuance of new shares through the exercise of stock acquisition rights issued as stock options.」
During the consolidated fiscal year, 54,400 new shares were issued through the exercise of stock acquisition rights. The potential shares outstanding at the end of the consolidated fiscal year also totalled 611,200, including those under the 10th series of stock acquisition rights and other rights. - FY2023-Q3MaterialisedAnnual report
「1 October 2022–31 December 2022 (Note) 44,000 7,074,354 4,428 1,187,920 4,428 1,180,920 (Note) Increase due to the exercise of stock acquisition rights.」
44,000 shares were added through the exercise of stock acquisition rights during the third-quarter accounting period, and dilution from potential shares continues to materialise through actual share issuance. - FY2023-Q2WorsenedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
The 10th series of paid stock acquisition rights was issued to 1 representative director. The number of underlying common shares is 250,000, and the exercise period runs from 19 July 2022 to 18 July 2032. This adds exposure to dilution from potential shares, but does not represent an issuance through exercise during the quarter. - FY2023-Q1MaterialisedAnnual report
「1 April 2022–30 June 2022 400 7,010,354 197 1,175,892 197 1,168,892 (Note) Increase due to the exercise of stock acquisition rights.」
400 shares were added through the exercise of stock acquisition rights during the first quarter, and dilution continues to materialise through actual share issuance. - FY2022MitigatedAnnual report
「As of the end of the consolidated fiscal year, the number of potential shares under stock acquisition rights was 217,100, equivalent to 3.1% of the 7,009,954 issued shares.」
While 42,000 shares were issued through the exercise of stock acquisition rights during the consolidated fiscal year, the potential share ratio declined from 3.7% to 3.1%. - FY2022-Q2MaterialisedAnnual report
「This was mainly attributable to ¥50 million in repayments of long-term borrowings, despite ¥13.912 million in proceeds from the issuance of shares upon the exercise of stock acquisition rights.」
¥13.912 million in proceeds was generated from the issuance of shares upon the exercise of stock acquisition rights, and dilution continues to materialise through actual share issuance. - FY2021MitigatedAnnual report
「As of the end of the consolidated fiscal year, the number of potential shares under stock acquisition rights was 260,600, equivalent to 3.7% of the 6,955,500 issued shares.」
Although 24,000 shares continued to be issued through the exercise of stock acquisition rights, the potential share ratio declined from 4.1% to 3.7%. - FY2021-Q2MaterialisedAnnual report
「This was mainly due to a ¥280 million decrease from the repayment of short-term borrowings, ¥500 million in proceeds from long-term borrowings, and ¥12 million in proceeds from the issuance of shares accompanying the exercise of stock acquisition rights.」
The issuance of shares accompanying the exercise of stock acquisition rights generated ¥12 million in proceeds, with dilution continuing to materialize as actual share issuance. - FY2021-Q1MaterialisedAnnual report
「1 April 2020–30 June 2020 24,000 6,732,300 6,000 1,073,155 6,000 1,066,155 (Note) Increase due to the exercise of stock acquisition rights.」
During the first quarter, the exercise of stock acquisition rights increased the number of shares by 24,000 and increased share capital and the capital reserve by ¥6,000 thousand each. Dilution continued to materialize as actual share issuance. - FY2020MitigatedAnnual report
「As of the end of the consolidated fiscal year, the number of potential shares from stock acquisition rights was 276,600, equivalent to 4.1% of the 6,708,300 issued shares.」
Although the exercise of stock acquisition rights resulted in the issuance of 78,600 shares during the consolidated fiscal year, the potential share ratio declined from 5.59% previously to 4.1%. - FY2020-Q3MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
During the third quarter accounting period, the exercise of stock acquisition rights increased the number of shares by 46,400 and increased share capital and the capital reserve by ¥6,640 thousand each. - FY2020-Q2MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
Between July and September 2019, the exercise of stock acquisition rights increased the number of shares by 29,000, with dilution from potential shares continuing to materialize as actual share issuance. - FY2020-Q1MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
During the first quarter, the exercise of stock acquisition rights increased the number of issued shares by 3,000, with dilution continuing to materialize as actual share issuance. - FY2019MitigatedAnnual report
「As of the end of the consolidated fiscal year, the number of potential shares from stock acquisition rights was 368,700, equivalent to 5.59% of the 6,596,400 issued shares.」
Although share issuance through the exercise of stock acquisition rights has continued, the potential share ratio declined from the previously reported 6.54% to 5.59%. - FY2019-Q4MaterialisedAnnual report
「1 November 2018–31 January 2019 (Note) Increase due to the exercise of stock acquisition rights.」
During the second quarter accounting period, the exercise of stock acquisition rights increased the total number of issued shares by 16,400, with dilution continuing to materialize as actual share issuance. - FY2019-Q3MaterialisedAnnual report
「1 August 2018–31 October 2018 (Note) Increase due to the exercise of stock acquisition rights.」
During the first quarter accounting period, the exercise of stock acquisition rights increased the total number of issued shares by 41,000, with dilution continuing to materialize as actual share issuance. - FY2018MaterialisedAnnual report
「As of the end of the fiscal year, the number of potential shares from stock acquisition rights was 427,400, equivalent to 6.54% of the 6,539,000 issued shares.」
While potential shares from stock acquisition rights represented 6.54%, the exercise of stock acquisition rights during the fiscal year also resulted in the issuance of 65,200 new shares. - FY2019-Q1MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
During the third quarter accounting period, the exercise of stock acquisition rights increased the total number of issued shares by 4,600, with dilution continuing to materialize as actual share issuance. - FY2018-Q4MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
During the second quarter accounting period, the exercise of stock acquisition rights increased the number of issued shares by 53,600 and increased share capital and the capital reserve by ¥7,847 thousand each, with dilution continuing to materialize as actual share issuance. - FY2018-Q3MaterialisedAnnual report
「1 August 2017–31 October 2017 (Note) 1 2,000 5,535,800 314 362,443 314 355,443」 2. Between 1 November 2017 and 30 November 2017, the exercise of stock acquisition rights increased the total number of issued shares by 33,400 and increased share capital and the capital reserve by ¥5,525 thousand each.」
During the quarter, 2,000 shares were issued through the exercise of stock acquisition rights, followed by a further 33,400 shares issued in November before the filing date, with dilution continuing to materialize as actual share issuance. - FY2017MaterialisedAnnual report
「The increase of 2,781,000 in the total number of issued common shares consisted of an increase of 2,766,200 from a stock split and an increase of 14,800 from the issuance of new shares through the exercise of stock acquisition rights issued as stock options.」
The exercise of stock acquisition rights resulted in the issuance of 14,800 new shares during the fiscal year, with the dilution risk materializing as actual share issuance. - FY2018-Q1MaterialisedAnnual report
「Between 1 May 2017 and 31 May 2017, the exercise of stock acquisition rights increased the total number of issued shares by 1,400 and increased share capital and the capital reserve by ¥257 thousand each.」
Following the previously reported 2,900 shares, the exercise of stock acquisition rights resulted in further share issuance and increases in share capital and the capital reserve, with the dilution risk again materializing as actual issuance. - FY2017-Q4MaterialisedAnnual report
「Between 1 February 2017 and 28 February 2017, the exercise of stock acquisition rights increased the total number of issued shares by 2,900 and increased share capital and the capital reserve by ¥830 thousand each.」
The exercise of stock acquisition rights had increased the number of issued shares by 2,900 as of the filing date, with the dilution risk from potential shares materializing as actual share issuance. - FY2016First statedAnnual report
「As of the end of the fiscal year, the number of potential shares from stock acquisition rights was 260,200, equivalent to 9.45% of the 2,752,800 issued shares.」
The company indicates that the exercise of stock acquisition rights could result in the issuance of potential shares equivalent to 9.45% of the total number of issued shares.